Alerts will be sent to your verified email
Verify EmailANUHPHR
Anuh Pharma
|
Lincoln Pharma
|
Wanbury
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.0 | 1.93 % | n/a |
Financials
|
|||
5 yr Average ROE
|
14.73 % | 15.94 % | -30.56 % |
5yr average Equity Multiplier
|
1.72 | 1.3 | -3.1 |
5yr Average Asset Turnover Ratio
|
1.28 | 0.84 | 1.51 |
5yr Avg Net Profit Margin
|
6.73 % | 14.61 % | 7.58 % |
Price to Book
|
3.38 | 1.73 | 16.23 |
P/E
|
23.24 | 14.07 | 31.51 |
5yr Avg Cash Conversion Cycle
|
32.26 Days | 24.49 Days | -119.82 Days |
Inventory Days
|
54.64 Days | 42.89 Days | 20.62 Days |
Days Receivable
|
101.36 Days | 90.22 Days | 49.78 Days |
Days Payable
|
121.84 Days | 111.35 Days | 205.91 Days |
5yr Average Interest Coverage Ratio
|
41.88 | 58.2 | 2.36 |
5yr Avg ROCE
|
19.85 % | 20.48 % | -51.74 % |
5yr Avg Operating Profit Margin
|
9.86 % | 18.48 % | 4.22 % |
5 yr average Debt to Equity
|
0.07 | 0.0 | -0.61 |
5yr CAGR Net Profit
|
33.23 % | 12.65 % | -2.79 % |
5yr Average Return on Assets
|
8.83 % | 12.28 % | 11.1 % |
Shareholdings
|
|||
Promoter Holding
|
69.92 % | 49.78 % | 39.76 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 76.74 % |
Change in Promoter Holding (3 Yrs)
|
-0.52 % | 7.73 % | -0.13 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |